Pharma Marketing Blog takes a look at how some drug advertising using Google Adwords is in violation of FDA rules:
What the ad doesn’t tell you — and what the FDA requires all drug ads that mention the brand name and the indication or benefits to tell you — is the major side effects. Or at least provide a direct link to a brief summary of the product labeling as in the Rozerem ad shown on the left. In this ad all you need to do to get the required information is to roll your mouse over the appropriately labeled area. Even so, this ad may also have been violative if it mentioned the indication because mouse rollovers may not be considered “fair balance” by the FDA. The Rozerem ad shown on the left and the Rozerem Adword shown above do not mention sleep, so they are fine as far as the FDA is concerned.
Similar Posts:
- How should pharmacy benefit managers (PBMs) and pharmacies communicate with physicians?
- Does jet lag really need to be cured?
- Why there needs to be a national healthcare information database
KevinMD.com on Facebook





{ 1 comment }
Big pharma companies should just not be allowed to use paid search marketing. We all know how long it takes people on the commercials to spit out all the risks, there is no possible way the pharmaceutical industry can grab your attention, promote the drug AND give all the risks in two 35-character long lines.
-Eric T.
Comments on this entry are closed.